Lindbrook Capital, LLC Essa Pharma Inc. Transaction History

Lindbrook Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$7.8 - $14.38 $5,850 - $10,785	-750 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$7.76 - $29.37 $9,700 - $36,712	-1,250 Reduced 62.5%	750 $6,000
Q2 2021 Jul 27, 2021	SELL	$24.17 - $34.28 $24,170 - $34,280	-1,000 Reduced 33.33%	2,000 $57,000
Q1 2021 Apr 28, 2021	BUY	$11.61 - $32.08 $34,830 - $96,240	3,000 New	3,000 $87,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $78M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.